<DOC>
	<DOCNO>NCT01709812</DOCNO>
	<brief_summary>A 6 month prospective , randomize , multicenter , control , parallel-group , open-label study RRMS patient assess impact individualize patient support program ( PSP ) treatment satisfaction evaluate whether individualized support improve satisfaction adherence medication compare standard care .</brief_summary>
	<brief_title>Effect Individualized Patient Support Program Treatment Satisfaction Fingolimod-treated Patients With RRMS</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Fingolimod Hydrochloride</mesh_term>
	<criteria>Patients eligible inclusion trial fulfill follow criterion : 1 . Written informed consent patient capable give withhold full informed consent must obtain assessment perform . 2 . Male female subject age 18 65 year . 3 . Subjects relapse remit MS define 2010 revise McDonald criterion . 4 . Patients Expanded Disability Status Scale ( EDSS ) score 06.5 . 5 . Patients Fingolimod Therapy , accord German label , least 6 month Study Visit 1 ( Day 1 ) . Patients fulfil follow criterion eligible inclusion study : 1 . Patients , register patient support program ( e.g . Extracare ) 2 . Patients relevant medically unstable condition , assess primary treat physician site . 3 . Any severe disability clinical impairment prevent patient meet study requirement investigator 's discretion 4 . History malignancy organ system , treat untreated , within past 5 year whether evidence local recurrence metastasis , exception localize basal cell carcinoma skin 5 . Patients receive investigational drug ( exclude Fingolimod ) therapy within 90 day 5 halflives prior screen , whichever longer . 6 . Pregnant nursing ( lactate ) woman , pregnancy define state female conception termination gestation , confirm positive pregnancy test ( serum ) 7 . Women childbearing potential unwilling use contraceptive precaution throughout study ( see section 7.13.6 detail ) . 8 . Simultaneous participation another clinical trial . Patients , already randomize trial earlier must include second time . Study personnel first degree relative investigator ( ) must include study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>